Perbedaan Kentanix Supra International Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Kentanix Supra International Tbk. diperdagangkan di Rp280 (kapitalisasi pasar 594,32 M, volume 24 jam 17 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Kentanix Supra International Tbk. jauh lebih besar — sekitar 3,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (96,7 rb vs 17 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KSIX | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 594,32 M | 167,37 M |
Volume | 17 rb | 96,7 rb |
Lot | 170 | 967 |
Perputaran | 4,73 jt | 23,82 jt |
Harga Rata-rata | 278,14 | 246,34 |
Nilai Transaksi | 4,73 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 278 | 248 |
Volume Ekuilibrium Indikatif | 500 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Selengkapnya di halaman KSIX →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →